产品名称： iFluor 549重组抗小鼠 CD19 单克隆抗体 (克隆号1D3) | 悉得（Syd Labs） PA007374 英文名： iFluor 549 Recombinant Anti-mouse CD19 Monoclonal ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and ...

Other potential treatments for NMOSD are also coming through the industry pipeline, including Viela Bio’s anti-CD19 antibody inebilizumab, which completed a first phase 3 trial earlier this year ...

Clinical Trials of ADCs for the Treatment of B-cell Malignancies Five ADCs targeting the B-lineage antigens CD22, CD19 and CD70 are ... single-agent IO demonstrated anti-tumor activity in relapsed ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. Anti-citrullinated protein/peptide antibodies (ACPA/anti-CCP) are a hallmark of rheumatoid ...

So we're really targeting the antibody-secreting cells in those that are producing pathogenic autoantibodies with an anti-CD19 directed B-cell depletion therapy. The study achieved its initial ...

Genentech and AC Immune’s semorinemab was the first anti-tau antibody to readout phase II data, in 2020. It didn’t slow the accumulation of tau in the brain, and missed its cognitive endpoints ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded its leadership team with the appointments of Jan ...